R. Matthew Cross

792 citations

16 papers · 412 indexed · h-index 10

Organic Chemistry top 10%
Public Health, Environmental and Occupational Health top 10%
Molecular Biology
Process Chemistry and Technology top 10%
Computational Theory and Mathematics top 10%

Co-authors: Roman Manetsch Dennis E. Kyle Tina Mutka Andrii Monastyrskyi Jeremy N. Burrows Kyung Woon Jung A. S. Nagle Ralph Nicholas Salvatore
Topics: Malaria Research and Control (5 papers)Phenothiazines and Benzothiazines Synthesis and Activities (4 papers)Research on Leishmaniasis Studies (4 papers)
Cited by: Process Chemistry and Technology Organic Chemistry Public Health, Environmental and Occupational Health
Journals: Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy The Journal of Organic Chemistry
Partner nations: United States Switzerland Australia

In The Last Decade

R. Matthew Cross

15 papers receiving 403 citations

Peers

Countries citing papers authored by R. Matthew Cross

Since Specialization

Citations

This map shows the geographic impact of R. Matthew Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Matthew Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Matthew Cross more than expected).

Fields of papers citing papers by R. Matthew Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Matthew Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Matthew Cross. The network helps show where R. Matthew Cross may publish in the future.

Co-authorship network of co-authors of R. Matthew Cross

This figure shows the co-authorship network connecting the top 25 collaborators of R. Matthew Cross. A scholar is included among the top collaborators of R. Matthew Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Matthew Cross. R. Matthew Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Key analogs of a uniquely potent synthetic vinblastine that contain modifications of the C20′ ethyl substituent 2017 ·Bioorganic & Medicinal Chemistry Letters ·Oliver Allemann,R. Matthew Cross,(unknown),(unknown),Dale L. Boger	9
2	Vinblastine 20′ Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance 2017 ·Journal of Medicinal Chemistry ·John C. Lukesh,Daniel W. Carney,Huijun Dong,R. Matthew Cross,(unknown),Katharine K. Duncan,Shouliang Yang,(unknown),(unknown),(unknown),Dale L. Boger	15
3	Orally Bioavailable 6-Chloro-7-methoxy-4(1H)-quinolones Efficacious against Multiple Stages of Plasmodium 2014 ·Journal of Medicinal Chemistry ·R. Matthew Cross,(unknown),Andrii Monastyrskyi,Alexis N. LaCrue,Fabián E. Saénz,(unknown),Tina Mutka,Karen L. White,David M. Shackleford,Ian Bathurst,Frank R. Fronczek,Łukasz Wojtas,Wayne C. Guida,Susan A. Charman,Jeremy N. Burrows,Dennis E. Kyle,Roman Manetsch	33
4	4-(1 H )-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10 H )-Ones Prevent the Transmission of Plasmodium falciparum to Anopheles freeborni 2013 ·Antimicrobial Agents and Chemotherapy ·Fabián E. Saénz,Alexis N. LaCrue,R. Matthew Cross,(unknown),Kenneth Udenze,Roman Manetsch,Dennis E. Kyle	18
5	Utilizing wide area maritime domain awareness (MDA) data to cue a remote surveillance system 2013 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·(unknown),R. Matthew Cross,(unknown),(unknown)	2
6	4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei 2012 ·Antimicrobial Agents and Chemotherapy ·Alexis N. LaCrue,Fabián E. Saénz,R. Matthew Cross,Kenneth Udenze,Andrii Monastyrskyi,Steven Stein,Tina Mutka,Roman Manetsch,Dennis E. Kyle	23
7	Optimization of 1,2,3,4-Tetrahydroacridin-9(10H)-ones as Antimalarials Utilizing Structure–Activity and Structure–Property Relationships 2011 ·Journal of Medicinal Chemistry ·R. Matthew Cross,(unknown),Tina Mutka,(unknown),(unknown),Dennis E. Kyle,Roman Manetsch	48
8	Synthesis, Antimalarial Activity, and Structure–Activity Relationship of 7-(2-Phenoxyethoxy)-4(1H)-quinolones 2011 ·Journal of Medicinal Chemistry ·R. Matthew Cross,(unknown),Tina Mutka,(unknown),Dennis E. Kyle,Roman Manetsch	47
9	Endochin Optimization: Structure−Activity and Structure−Property Relationship Studies of 3-Substituted 2-Methyl-4(1H)-quinolones with Antimalarial Activity 2010 ·Journal of Medicinal Chemistry ·R. Matthew Cross,Andrii Monastyrskyi,Tina Mutka,Jeremy N. Burrows,Dennis E. Kyle,Roman Manetsch	88
10	Divergent Route to Access Structurally Diverse 4-Quinolones via Mono or Sequential Cross-Couplings 2010 ·The Journal of Organic Chemistry ·R. Matthew Cross,Roman Manetsch	47
11	Field testing the wide-field-of-view imaging spectrometer(WFIS) 2004 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Robert E. Haring,Randy Pollock,R. Matthew Cross,Brian M. Sutin	0
12	Selective mono protection of diols, diamines, and amino alcohols using cesium bases 2003 ·Tetrahedron Letters ·A. S. Nagle,Ralph Nicholas Salvatore,R. Matthew Cross,(unknown),(unknown),Cheol Hwan Yoon,Kyung Woon Jung	17
13	Wide-field-of-view imaging spectrometer (WFIS) engineering model laboratory tests and field demonstrations 2003 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Robert E. Haring,Randy Pollock,R. Matthew Cross	3
14	Oxygen A-band spectrometer breadboard for the Orbiting Carbon Observatory 2002 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Robert E. Haring,Randy Pollock,R. Matthew Cross,David Crisp	2
15	<title>Wide-field-of-view imaging spectrometer (WFIS): from a laboratory demonstration to a fully functional engineering model</title> 2002 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Robert E. Haring,Randy Pollock,R. Matthew Cross,(unknown)	2
16	Efficient Cs2CO3-promoted solution and solid phase synthesis of carbonates and carbamates in the presence of TBAI 2002 ·Tetrahedron ·Ralph Nicholas Salvatore,Feixia Chu,A. S. Nagle,(unknown),R. Matthew Cross,Kyung Woon Jung	58

About R. Matthew Cross

R. Matthew Cross is a scholar working on Process Chemistry and Technology, Organic Chemistry and Public Health, Environmental and Occupational Health, having authored 16 papers that have together received 412 indexed citations. Recurring topics across this work include Malaria Research and Control (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Research on Leishmaniasis Studies (4 papers). The work is most often cited by research in Process Chemistry and Technology (50 citations), Organic Chemistry (219 citations) and Public Health, Environmental and Occupational Health (144 citations). R. Matthew Cross has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Roman Manetsch, Dennis E. Kyle, Tina Mutka, Andrii Monastyrskyi, Jeremy N. Burrows, Kyung Woon Jung, A. S. Nagle, Ralph Nicholas Salvatore, Feixia Chu and Fabián E. Saénz. Their work appears in journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact